283 related articles for article (PubMed ID: 9787740)
21. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
22. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
24. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
Pasquier D; Bijmolt S; Veninga T; Rezvoy N; Villa S; Krengli M; Weber DC; Baumert BG; Canyilmaz E; Yalman D; Szutowicz E; Tzuk-Shina T; Mirimanoff RO;
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1388-93. PubMed ID: 18294779
[TBL] [Abstract][Full Text] [Related]
25. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
26. Radiotherapy for atypical meningiomas.
Mair R; Morris K; Scott I; Carroll TA
J Neurosurg; 2011 Oct; 115(4):811-9. PubMed ID: 21699480
[TBL] [Abstract][Full Text] [Related]
27. Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.
Weber DC; Schneider R; Goitein G; Koch T; Ares C; Geismar JH; Schertler A; Bolsi A; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):865-71. PubMed ID: 22138457
[TBL] [Abstract][Full Text] [Related]
28. Olfactory groove meningioma: discussion of clinical presentation and surgical outcomes following excision via the subcranial approach.
Pepper JP; Hecht SL; Gebarski SS; Lin EM; Sullivan SE; Marentette LJ
Laryngoscope; 2011 Nov; 121(11):2282-9. PubMed ID: 21994142
[TBL] [Abstract][Full Text] [Related]
29. Treatment of atypical meningioma.
Jo K; Park HJ; Nam DH; Lee JI; Kong DS; Park K; Kim JH
J Clin Neurosci; 2010 Nov; 17(11):1362-6. PubMed ID: 20800497
[TBL] [Abstract][Full Text] [Related]
30. Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients.
Rushing EJ; Olsen C; Mena H; Rueda ME; Lee YS; Keating RF; Packer RJ; Santi M
J Neurosurg; 2005 Dec; 103(6 Suppl):489-95. PubMed ID: 16383246
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children.
Elliott RE; Hsieh K; Hochm T; Belitskaya-Levy I; Wisoff J; Wisoff JH
J Neurosurg Pediatr; 2010 Jan; 5(1):30-48. PubMed ID: 20043735
[TBL] [Abstract][Full Text] [Related]
32. The selection of the optimal therapeutic strategy for petroclival meningiomas.
Park CK; Jung HW; Kim JE; Paek SH; Kim DG
Surg Neurol; 2006 Aug; 66(2):160-5; discussion 165-6. PubMed ID: 16876612
[TBL] [Abstract][Full Text] [Related]
33. Radical treatment strategies improve the long-term outcome of recurrent atypical meningiomas.
Li F; Lai ZP; Lin JK; Zhu G; Feng H
Chin Med J (Engl); 2011 Aug; 124(15):2387-91. PubMed ID: 22029080
[TBL] [Abstract][Full Text] [Related]
34. Petroclival meningiomas: multimodality treatment and outcomes at long-term follow-up.
Natarajan SK; Sekhar LN; Schessel D; Morita A
Neurosurgery; 2007 Jun; 60(6):965-79; discussion 979-81. PubMed ID: 17538370
[TBL] [Abstract][Full Text] [Related]
35. Benign versus atypical meningiomas: risk factors predicting recurrence.
Nowak A; Dziedzic T; Krych P; Czernicki T; Kunert P; Marchel A
Neurol Neurochir Pol; 2015; 49(1):1-10. PubMed ID: 25666766
[TBL] [Abstract][Full Text] [Related]
36. Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature.
Soyuer S; Chang EL; Selek U; McCutcheon IE; Maor MH
Cancer; 2004 Apr; 100(7):1491-7. PubMed ID: 15042684
[TBL] [Abstract][Full Text] [Related]
37. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
38. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K
World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464
[TBL] [Abstract][Full Text] [Related]
40. Is gross-total resection sufficient treatment for posterior fossa ependymomas?
Rogers L; Pueschel J; Spetzler R; Shapiro W; Coons S; Thomas T; Speiser B
J Neurosurg; 2005 Apr; 102(4):629-36. PubMed ID: 15871504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
